QA: Biovie INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001580149_2023_Biovie_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001580149, Biovie INC

  xvar xval
0 AssetsCurrent 18,779,595
1 IntangibleAssetsNetIncludingGoodwill 1,212,183
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 122,816
4 LiabilitiesCurrent 4,169,174
5 LiabilitiesNoncurrent 135,799
6 remainder_Liabilities 12,138,686
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,042,843
9 ResearchAndDevelopmentExpense 16,856,239
10 remainder_Expenses -830,720
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 20,114,594
1 Liabilities 16,443,659
2 Expenses 24,068,362
3 Revenues 0
4 StockholdersEquity 3,670,935
5 NetIncome -24,068,362
6 ComprehensiveNetIncome -24,068,362
7 BaseVar 30,313,308
8 EconomicCapitalRatiobeforeLimitedLiability -0.879
9 EconomicCapitalRatio 1.33

Edgar->Model Mapping

Feature Distribution

Change over Time